Ibere Pharmaceuticals
Ibere Pharmaceuticals (IBER) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · IBER · as of Dec 31, 2022
Ownership Breakdown
48
Institutional Holders
$126.08M
Total Inst. Value
▲ $6.71M vs Q3
17.25M
Shares Outstanding
freeFloat 72.29%
12.50M
13F Shares Held
▲ 449,723 vs Q3
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
IBER largest shareholders · institutional ownership
Q4 2022 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
GLAZER CAPITAL, LLC blank checks | 1.33M | 7.71% | 7.71% | $13.42B | Feb 14, 2023 | ▲ 243.6K |
MAGNETAR FINANCIAL LLC blank checks | 785.9K | 4.56% | 4.56% | $7.93B | Feb 14, 2023 | — held |
HUDSON BAY CAPITAL MANAGEMENT LP blank checks | 716.6K | 4.15% | 4.15% | $7.23B | Feb 14, 2023 | — held |
POLAR ASSET MANAGEMENT PARTNERS INC. blank checks | 678.9K | 3.94% | 3.94% | $6.85B | Feb 14, 2023 | — held |
ARISTEIA CAPITAL LLC blank checks | 675.2K | 3.91% | 3.91% | $6.81B | Feb 14, 2023 | ▲ 250.0K |
MILLENNIUM MANAGEMENT LLC blank checks | 660.7K | 3.83% | 3.83% | $6.67B | Feb 14, 2023 | ▲ 8.0K |
FIRST TRUST CAPITAL MANAGEMENT L.P. blank checks | 542.9K | 3.15% | 3.15% | $5.48B | Feb 14, 2023 | — held |
MARSHALL WACE, LLP blank checks | 539.8K | 3.13% | 3.13% | $5.45B | Feb 14, 2023 | — held |
PERISCOPE CAPITAL INC. blank checks | 470.4K | 2.73% | 2.73% | $4.75B | Feb 13, 2023 | ▲ 14.2K |
KIM, LLC blank checks | 450.0K | 2.61% | 2.61% | $4.54B | Feb 14, 2023 | — held |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q4 2022 vs prior quarter
Q4 2022
7
Increased
+547.0K shares7
New Positions
first time holders4
Decreased
−129.8K shares2
Sold Out
fully exitedNet shares change (top 50)
+417.2K
+547.0K / −129.8K
Net new holders
+8
7 new / 2 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
IBER insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
1
Buy transactions
5
Sell transactions
0.20
Buy/Sell ratio
$3M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Vollmer Louis J. director | Mar 2, 2021 | Purchase | 10,000 | $10.00 | $100.0K | 35.0K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Ibere Pharmaceuticals (IBER) is primarily owned by institutional investors, who hold approximately 72.4% of total shares outstanding. Company insiders own approximately 27.71%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of Ibere Pharmaceuticals is GLAZER CAPITAL, LLC, holding approximately 1.33 million shares — equal to 7.71% of outstanding shares — as of December 31, 2022.
A total of 48 institutional investors currently hold IBER stock, with a combined institutional value of approximately $126,082,358 as of the most recent 13F filing period.
Frequently asked questions
IBER ownershipIbere Pharmaceuticals (IBER) is primarily owned by institutional investors, who hold approximately 72.4% of shares. The largest shareholder is GLAZER CAPITAL, LLC with a 7.71% stake. Company insiders hold 27.71%. Data sourced from SEC Form 13F as of December 31, 2022.